Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Conditions: Pancreatic Cancer Interventions: Drug: NP137 Sponsors: Nabeel Badri; NETRIS Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Pharmaceuticals | Research | Study